Expression of miR-188 and 362 Induced by Erythropoietin Stimulation in a Human Erythrocytic Leukemia Cell Line.

Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 2210-2210
Author(s):  
Keiichi Sugiura ◽  
Nobuyoshi Kosaka ◽  
Yusuke Yamamoto ◽  
Yusuke Yoshioka ◽  
Hiroshi Miyazaki ◽  
...  

Abstract MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the post-transcriptional level and participate in a lot of biological processes. Several studies indicated that miRNAs play an important role in hematopoietic system. It has not been elucidated well about miRNAs involved in cytokine-regulated molecular mechanisms in cellular proliferation and differentiation. We screened specific miRNAs expressed in human leukemia cell lines, UT-7 and its sublines UT-7/GM, UT-7/EPO and UT-7/TPO, which exhibit hematopoietic lineage properties depending on cytokine stimuli by GM-CSF, erythropoietin (EPO), or thrombopoietin (TPO), respectively. The expression profiles of 470 miRNAs in all were analyzed using LNA-based microarray between UT-7/GM, UT-7/EPO and UT-7/TPO cells. The initial microarray data were validated, and specific expressions of several miRNAs were confirmed using quantitative real-time PCR. Especially, the expression levels of miR-188 and 362 clustered on X chromosome were significantly higher in UT-7/EPO cells as compared with those in UT-7, UT-7/GM and UT-7/TPO cells. To assess the effect of EPO on the expression of miR-188 and 362, UT-7/EPO cells were cultured under various concentration of EPO (0 to 10 U/ml) after cytokine withdrawal for 24 hours. Quantification of miRNAs expression by real-time PCR showed that miR-188 and 362 were increased 2- to 20-fold by EPO stimuli, but both expressions were not in dose-dependent manner. Furthermore, the addition of EPO (1 ng/ml) to growth factor-derived UT-7 cells which were cultured for 1 month caused a 4- to 50-fold increase of miR-362 expression; while miR-188 expression was not increased. Similarly, EPO induced the expression of miR-362 in erythroleukemic cell line TF-1. The expression levels of miR-188 and miR-362 were significantly higher in UT-7/EPO with erythrocytic features than UT-7/GM and UT-7/TPO cells, in addition, expressions of both miRNAs were induced by EPO stimuli in UT-7/EPO cells, suggesting that miR-188 and miR-362 are involved in lineage specific molecular mechanisms of erythropoiesis.

Blood ◽  
1991 ◽  
Vol 78 (11) ◽  
pp. 2834-2840 ◽  
Author(s):  
A Kuriu ◽  
H Ikeda ◽  
Y Kanakura ◽  
JD Griffin ◽  
B Druker ◽  
...  

Abstract We investigated the expression, degree of phosphorylation, and activation of the proto-oncogene c-kit product before and after stimulation with the c-kit ligand in a human factor-dependent myeloid leukemia cell line, MO7E. The culture supernatant of the BALB/3T3 fibroblast cell line, which contains the ligand for the murine c-kit product, was found to stimulate proliferation of the MO7E cell line in a dose-dependent manner. The proliferation was significantly inhibited by a tyrosine kinase inhibitor, genistein. An immunoblot technique with a monoclonal antibody specific for phosphotyrosine, showed that there was rapid, dose-dependent tyrosine-phosphorylation of the c-kit product in response to murine c-kit ligand. Furthermore, the murine c-kit ligand increased autokinase activity of the c-kit product in vitro. Similar results were obtained with human stem cell factor (SCF), a recombinant human ligand for the c-kit product. These results suggest that the phosphorylation and activation of the c-kit product are involved in proliferative signals of some human leukemia cells, as well as of normal hematopoietic cells.


Blood ◽  
1991 ◽  
Vol 78 (11) ◽  
pp. 2834-2840 ◽  
Author(s):  
A Kuriu ◽  
H Ikeda ◽  
Y Kanakura ◽  
JD Griffin ◽  
B Druker ◽  
...  

We investigated the expression, degree of phosphorylation, and activation of the proto-oncogene c-kit product before and after stimulation with the c-kit ligand in a human factor-dependent myeloid leukemia cell line, MO7E. The culture supernatant of the BALB/3T3 fibroblast cell line, which contains the ligand for the murine c-kit product, was found to stimulate proliferation of the MO7E cell line in a dose-dependent manner. The proliferation was significantly inhibited by a tyrosine kinase inhibitor, genistein. An immunoblot technique with a monoclonal antibody specific for phosphotyrosine, showed that there was rapid, dose-dependent tyrosine-phosphorylation of the c-kit product in response to murine c-kit ligand. Furthermore, the murine c-kit ligand increased autokinase activity of the c-kit product in vitro. Similar results were obtained with human stem cell factor (SCF), a recombinant human ligand for the c-kit product. These results suggest that the phosphorylation and activation of the c-kit product are involved in proliferative signals of some human leukemia cells, as well as of normal hematopoietic cells.


Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 4828-4828
Author(s):  
Bao-An Chen ◽  
Xue-Yun Shan ◽  
Jian Cheng ◽  
Feng Gao ◽  
Jia-Hua Ding ◽  
...  

Abstract Abstract 4828 Objective This study was aimed to investigate the reversible effect of tyrosine kinase inhibitors(TKI)on Multidrug resistance cell line K562/A02. Methods The expression levels of mdr-1 mRNA and bcr-abl mRNA were assayed by RT-PCR. The protein levels of P-glycoprotein (P-gp) and P210 were detected by Western blot. The DNR accumulation of K562/A02 cells were analyzed by flow cytometry (FCM). Results Analysis of the inhibition rate showed that 0.0625μmol/L Imatinib or 5nM Nilotinib alone had no effect on the inhibition of K562/A02 cells. The fluorescence intensity of intracellular DNR of Imatinib, Nilotinib in K562/A02 cells was 7.85%, 12.02% (respectively of that in K562 cells). Imatinib or Nilotonib alone could decrease the mdr-1 mRNA and bcr-abl mRNA expression levels (Imatinib 0.65±0.02, 0.87±0.02; Nilotinib 0.48±0.04, 0.73 ±0.02) respectively, all these of which were significantly lower than the K562/A02 cells group 0.96±0.01, 1.87±0.04. The P-gp and P210 protein expression levels were also down after treated with different drugs (Imatinib 0.74±0.02, 0.68±0.01; Nilotinib 0.61±0.05, 0.60±0.01; the K562/A02 cells group 0.93±0.01, 1.25±0.03). Conclusion It is concluded that multidrug resistance (MDR) can be partially reversed by Imatinib or Nilotinib. The effect of Nilotinib was greater than Imatinib. Disclosures No relevant conflicts of interest to declare.


Leukemia ◽  
2000 ◽  
Vol 14 (2) ◽  
pp. 299-306 ◽  
Author(s):  
Y Nomura ◽  
O Inanami ◽  
K Takahashi ◽  
A Matsuda ◽  
M Kuwabara

1984 ◽  
Vol 89 (1) ◽  
pp. 122-131 ◽  
Author(s):  
Atsushi Komiyama ◽  
Yukiaki Miyagawa ◽  
Kohki Aoyama ◽  
Taro Akabane ◽  
Yoshio Uehara

1992 ◽  
Vol 7 (1-2) ◽  
pp. 157-164 ◽  
Author(s):  
Toshio Kakihara ◽  
Toshiyuki Yamada ◽  
Takeaki Fukuda ◽  
Yoshihisa Ohnishi ◽  
Kenji Kishi ◽  
...  

2012 ◽  
Vol 13 (12) ◽  
pp. 6191-6196 ◽  
Author(s):  
Jun Liu ◽  
Shi-Zhong Cai ◽  
Yue Zhou ◽  
Xian-Ping Zhang ◽  
Dian-Feng Liu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document